Can AI change the future of opioid use disorder treatment?
On this episode of Amplified CEO, host Richard Stroupe sits down with David Reeser, Founder and CEO of OpiAID, a groundbreaking company using artificial intelligence to transform the way we treat opioid use disorder. From his early passion for healthcare to pioneering predictive analytics, David shares how real-time biometric data and AI-driven insights are reshaping recovery.
@
Sponsored by Cape Fear Ventures | @
Produced by Topsail Insider | @
This episode edited by Nomadic Orca | @
